Related Experiment Video
Updated: May 7, 2026

08:11
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
Spontaneous and experimental metastasis models: nude mice
1Department of Cancer Biology, M.D., Anderson Cancer Centre, Houston, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|October 5, 2013
Summary
Immunodeficient mice, particularly nude mice, are crucial for cancer research, enabling in vivo studies of tumor cell metastasis. These models help test anti-metastatic therapies by examining spontaneous and experimental metastasis.
Area of Science:
- Oncology
- Immunology
- Animal Models
Background:
- Immunodeficient mice are essential in vivo models for cancer research.
- Athymic (nude) mice are frequently used to study tumor growth, invasion, and metastasis.
- Understanding metastasis is critical for developing effective cancer therapies.
Purpose of the Study:
- To describe experimental designs for studying cancer metastasis in vivo using immunodeficient mice.
- To highlight the utility of nude mouse models for investigating the metastatic phenotype.
- To emphasize the role of these models in preclinical testing of anti-metastatic drugs.
Main Methods:
- Utilizing immunodeficient nude mice for in vivo cancer research.
- Employing spontaneous metastasis models, often initiated by orthotopic injection of human cancer cells.
- Using experimental metastasis models involving intravascular injection of tumor cells.
Main Results:
- Nude mice support the study of human cancer cell tumorigenicity and metastatic potential in vivo.
- Spontaneous metastasis models assess cell dissemination from a primary tumor.
- Experimental metastasis models evaluate tumor cell arrest, extravasation, and organ colonization.
Conclusions:
- Well-designed nude mouse models with established human cancer cell lines generate crucial data on metastatic phenotypes.
- These preclinical models are invaluable for evaluating the efficacy of novel anti-metastatic therapies.
- In vivo metastasis studies in immunodeficient mice advance cancer research and therapeutic development.

